1 INTRODUCTION 1.1. OVERVIEW OF THE GLOBAL ADVANCED WOUND CARE MARKET 1.2. MARKET SEGMENTATION & COVERAGE 1.2.1. CURRENCY AND PRICING 1.2.2. LIMITATION 1.2.3 STAKEHOLDERS 2 RESEARCH METHODOLOGY 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE ADVANCED WOUND CARE MARKET SIZE 2.2.1. MARKET CRACKDOWN APPROACH 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3. DATA TRIANGULATION 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES 2.2.6. PORTER’S FIVE FORCES MATRIX 2.4. GLOBAL ADVANCED WOUND CARE MARKET: RESEARCH SNAPSHOT 2.3. ASSUMPTIONS 3 MARKET LANDSCAPE SUMMARY 4 PREMIUM INSIGHTS 4.1. OVERVIEW 4.2. RADIOTHERAPY MARKET: KEY PRIMARY INSIGHTS 4.3. MARKET OVERVIEW 4.3.1. DRIVERS 4.3.1.1. INCREASING ACCEPTANCE OF WOUND CARE BIOLOGICS 4.3.1.2. TECHNOLOGICALLY BENEFICIAL 4.3.1.3. INCREASING POOL OF AGING POPULATION AND DIABETES 4.3.1.4. INCREASING DEMAND FOR MODERN HEALTHCARE IN ASIA 4.3.2. RESTRAINTS 4.3.3. OPPURTUNITIES 4.3.4. THREATS 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES 5 ADVANCED WOUND CARE MARKET, BY TYPE 5.1. OVERVIEW 5.2. ADVANCED WOUND CARE DRESSINGS, BY PRODUCT TYPE 5.2.1. FILM DRESSINGS 5.2.2. FOAM DRESSINGS 5.2.3. HYDROGELS 5.2.4. ALGINATES 5.2.5. WOUND CONTACT LAYERS 5.2.6. SUPER ABSORBENT DRESSINGS 5.3. ADVANCED WOUND CARE BIOLOGICS, BY PRODUCT TYPE 5.3.1. ALLOGRAFTS 5.3.2. SYNTHETIC SKIN GRAFTS 5.3.3. XENOGRAFTS 5.3.4. GROWTH FACTORS 5.3.4.1. PLATELET-DERIVED GROWTH FACTOR (PDGF) 5.3.4.2. PLATELET RICH PLASMA (PRP) 5.3.4.3. EPIDERMAL GROWTH FACTORS (EGF) 5.3.4.4. BASIC FIBROBLAST GROWTH FACTOR (BFGF) 5.3.4.5. GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) 5.3.4.6. TALACTOFERRIN ALFA 5.3.4.6. THROMBIN PEPTIDE (TP508) 5.3.4.6. KERATINOCYTE GROWTH FACTOR (KGF) 5.4. ADVANCED WOUND CARE THERAPY DEVICES, BY PRODUCT TYPE 5.4.1. NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT) 5.4.1.1. STAND-ALONE NPWT DEVICES 5.4.1.2. PORTABLE NPWT DEVICES 5.4.1.3. DISPOSABLE NPWT DEVICES 5.4.2. PRESSURE RELIEF DEVICES (PRD) 5.4.2.1. MATRESSES 5.4.2.2. BEDS 5.4.3. HYBERBARIC OXYGEN CHAMBERS 5.4.3.1. MONOPLACE 5.4.3.2. MULTIPLACE 5.4.3.3. TOPICAL 5.4.4. WOUND DEBRIDEMENT DEVICES 5.4.4.1. HYDROSURGICAL 5.4.4.2. MECHANICAL 5.4.4.3. ULTRASOUND 5.4.4.4. OTHERS 5.4.5. PHYSICAL THERAPIES 5.4.5.1. LASER THERAPY 5.4.5.2. ELECTRICAL STIMULATION 5.4.5.3. EXTERNAL SHOCK WAVE THERAPIES (ESWT) 5.4.5.4. SALINE MIST THERAPY 6 ADVANCED WOUND CARE MARKET, BY WOUND TYPE 6.1. OVERVIEW 6.2. SURGICAL WOUNDS 6.3. DIABETIC ULCERS 6.4. PRESSURE ULCERS 6.5. VENOUS ULCERS 6.6. BURNS 6.7. OTHERS 7 ADVANCED WOUND CARE MARKET, BY END-USER 7.1. OVERVIEW 7.2. HOSPITALS 7.3. WOUND CARE CENTERS 7.4. AMBULATORY CENTERS 7.5. HOME HEALTHCARE 7.6. CLINICS 7.7. COMMUNITY HEALTHCARE 8 ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL 8.1. OVERVIEW 8.2. DIRECT TENDERS 8.3. RETAIL 9 ADVANCED WOUNDCARE MARKET, BY GEOGRAPHY 9.1. COUNTRYWISE ADVANCED WOUND CARE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) 9.1.1. NORTH AMERICA 9.1.1.1. U.S. 9.1.1.2. CANADA 9.1.1.3. MEXICO 9.1.2. EUROPE 9.1.2.1. GERMANY 9.1.2.2. FRANCE 9.1.2.3. U.K. 9.1.2.4. ITALY 9.1.2.5. SPAIN 9.1.2.6. RUSSIA 9.1.2.7. TURKEY 9.1.2.8. BELGIUM 9.1.2.9. NETHERLANDS 9.1.2.10. SWITZERLAND 9.1.2.11. REST OF EUROPE 9.1.3. ASIA-PACIFIC (APAC) 9.1.3.1. JAPAN 9.1.3.2. CHINA 9.1.3.3. SOUTH KOREA 9.1.3.4. INDIA 9.1.3.5. AUSTRALIA 9.1.3.6. SINGAPORE 9.1.3.7. THAILAND 9.1.3.8. MALAYSIA 9.1.3.9. INDONESIA 9.1.3.10. PHILIPPINES 9.1.3.11. REST OF APAC 9.1.4. LATIN AMERICA 9.1.4.1. BRAZIL 9.1.4.2. REST OF LATIN AMERICA 9.1.5. MIDDLE EAST AND AFRICA 9.1.5.1. SOUTH AFRICA 9.1.5.2. REST OF MIDDLE EAST AND AFRICA 9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 10 ADVANCED WOUND CARE MARKET:COMPETITVE LANDSCAPE 10.1. GLOBAL ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.2. U.S. ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.3. EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.4. APAC ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.5. SOUTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.6. MEA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS 10.7. MERGERS & ACQUISITIONS 10.8. NEW PRODUCT DEVELOPMENT & APPROVALS 10.9. EXPANSIONS 10.10. REGULATORY CHANGES 10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 11 ADVANCED WOUND CARE MARKET, COMPANY PROFILES 11.1 3M 11.1.1 COMPANY OVERVIEW 11.1.2 SWOT ANALYSIS 11.1.3 REVENUE ANALYSIS 11.1.4 PRODUCT PORTFOLIO 11.1.5 RECENT DEVELOPEMENTS 11.1.5 DATA BRIDGE ANALYSIS 11.2 SMITH AND NEPHEW 11.2.1 COMPANY OVERVIEW 11.2.2 SWOT ANALYSIS 11.2.3 REVENUE ANALYSIS 11.2.4 PRODUCT PORTFOLIO 11.2.5 RECENT DEVELOPEMENTS 11.2.6 DATA BRIDGE ANALYSIS 11.3 MEDTRONIC 11.3.1 COMPANY OVERVIEW 11.3.2 SWOT ANALYSIS 11.3.3 REVENUE ANALYSIS 11.3.4 PRODUCT PORTFOLIO 11.3.5 RECENT DEVELOPEMENTS 11.3.5 DATA BRIDGE ANALYSIS 11.4 ACELITY L.P. INC. 11.4.1 COMPANY OVERVIEW 11.4.2 SWOT ANALYSIS 11.4.3 REVENUE ANALYSIS 11.4.4 PRODUCT PORTFOLIO 11.4.5 RECENT DEVELOPEMENTS 11.4.5 DATA BRIDGE ANALYSIS 11.5 BECTON, DICKINSON AND COMPANY 11.5.1 COMPANY OVERVIEW 11.5.2 SWOT ANALYSIS 11.5.3 REVENUE ANALYSIS 11.5.4 PRODUCT PORTFOLIO 11.5.5 RECENT DEVELOPEMENTS 11.5.5 DATA BRIDGE ANALYSIS 11.6 MOLYNCKE HEALTH CARE AB 11.6.1 COMPANY OVERVIEW 11.6.2 SWOT ANALYSIS 11.6.3 REVENUE ANALYSIS 11.6.4 PRODUCT PORTFOLIO 11.6.5 RECENT DEVELOPEMENTS 11.6.5 DATA BRIDGE ANALYSIS 11.7 CONVATEC INC. 11.7.1 COMPANY OVERVIEW 11.7.2 SWOT ANALYSIS 11.7.3 REVENUE ANALYSIS 11.7.4 PRODUCT PORTFOLIO 11.7.5 RECENT DEVELOPEMENTS 11.7.5 DATA BRIDGE ANALYSIS 11.8 BAXTER 11.8.1 COMPANY OVERVIEW 11.8.2 SWOT ANALYSIS 11.8.3 REVENUE ANALYSIS 11.8.4 PRODUCT PORTFOLIO 11.8.5 RECENT DEVELOPEMENTS 11.8.5 DATA BRIDGE ANALYSIS 11.9 COLOPLAST 11.9.1 COMPANY OVERVIEW 11.9.2 SWOT ANALYSIS 11.9.3 REVENUE ANALYSIS 11.9.4 PRODUCT PORTFOLIO 11.9.5 RECENT DEVELOPEMENTS 11.9.5 DATA BRIDGE ANALYSIS 11.9 ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY) 11.9.1 COMPANY OVERVIEW 11.9.2 SWOT ANALYSIS 11.9.3 REVENUE ANALYSIS 11.9.4 PRODUCT PORTFOLIO 11.9.5 RECENT DEVELOPEMENTS 11.9.5 DATA BRIDGE ANALYSIS 11.9 HOLLISTER INCORPORATED 11.9.1 COMPANY OVERVIEW 11.9.2 SWOT ANALYSIS 11.9.3 REVENUE ANALYSIS 11.9.4 PRODUCT PORTFOLIO 11.9.5 RECENT DEVELOPEMENTS 11.9.5 DATA BRIDGE ANALYSIS 11.10 INTEGRA LIFESCIENCES CORPORATION 11.10.1 COMPANY OVERVIEW 11.10.2 SWOT ANALYSIS 11.10.3 REVENUE ANALYSIS 11.10.4 PRODUCT PORTFOLIO 11.10.5 RECENT DEVELOPEMENTS 11.10.5 DATA BRIDGE ANALYSIS 11.11 DERMA SCIENCES INC. 11.11.1 COMPANY OVERVIEW 11.11.2 SWOT ANALYSIS 11.11.3 REVENUE ANALYSIS 11.11.4 PRODUCT PORTFOLIO 11.11.5 RECENT DEVELOPEMENTS 11.11.5 DATA BRIDGE ANALYSIS 11.12 SPIRACUR, INC. 11.12.1 COMPANY OVERVIEW 11.12.2 SWOT ANALYSIS 11.12.3 REVENUE ANALYSIS 11.12.4 PRODUCT PORTFOLIO 11.12.5 RECENT DEVELOPEMENTS 11.12.5 DATA BRIDGE ANALYSIS 11.13 MEDLINE INDUSTRIES 11.13.1 COMPANY OVERVIEW 11.13.2 SWOT ANALYSIS 11.13.3 REVENUE ANALYSIS 11.13.4 PRODUCT PORTFOLIO 11.13.5 RECENT DEVELOPEMENTS 11.13.5 DATA BRIDGE ANALYSIS 11.14 MIMEDX GROUP 11.14.1 COMPANY OVERVIEW 11.14.2 SWOT ANALYSIS 11.14.3 REVENUE ANALYSIS 11.14.4 PRODUCT PORTFOLIO 11.14.5 RECENT DEVELOPEMENTS 11.14.5 DATA BRIDGE ANALYSIS 11.15 ORGANOGENESIS, INC. 11.15.1 COMPANY OVERVIEW 11.15.2 SWOT ANALYSIS 11.15.3 REVENUE ANALYSIS 11.15.4 PRODUCT PORTFOLIO 11.15.5 RECENT DEVELOPEMENTS 11.15.5 DATA BRIDGE ANALYSIS 11.16 TALLEY GROUP 11.16.1 COMPANY OVERVIEW 11.16.2 SWOT ANALYSIS 11.16.3 REVENUE ANALYSIS 11.16.4 PRODUCT PORTFOLIO 11.16.5 RECENT DEVELOPEMENTS 11.16.5 DATA BRIDGE ANALYSIS 11.17 BSN MEDICAL 11.17.1 COMPANY OVERVIEW 11.17.2 SWOT ANALYSIS 11.17.3 REVENUE ANALYSIS 11.17.4 PRODUCT PORTFOLIO 11.17.5 RECENT DEVELOPEMENTS 11.17.5 DATA BRIDGE ANALYSIS 11.18 DEVON MEDICAL PRODUCTS 11.18.1 COMPANY OVERVIEW 11.18.2 SWOT ANALYSIS 11.18.3 REVENUE ANALYSIS 11.18.4 PRODUCT PORTFOLIO 11.18.5 RECENT DEVELOPEMENTS 11.18.5 DATA BRIDGE ANALYSIS 11.19 HUMAN BIOSCIENCES, INC. 11.19.1 COMPANY OVERVIEW 11.19.2 SWOT ANALYSIS 11.19.3 REVENUE ANALYSIS 11.19.4 PRODUCT PORTFOLIO 11.19.5 RECENT DEVELOPEMENTS 11.19.5 DATA BRIDGE ANALYSIS 11.20 B.BRAUN MELSUNGEN AG 11.20.1 COMPANY OVERVIEW 11.20.2 SWOT ANALYSIS 11.20.3 REVENUE ANALYSIS 11.20.4 PRODUCT PORTFOLIO 11.20.5 RECENT DEVELOPEMENTS 11.20.5 DATA BRIDGE ANALYSIS 11.21 CARDINAL HEALTH 11.21.1 COMPANY OVERVIEW 11.21.2 SWOT ANALYSIS 11.21.3 REVENUE ANALYSIS 11.21.4 PRODUCT PORTFOLIO 11.21.5 RECENT DEVELOPEMENTS 11.21.5 DATA BRIDGE ANALYSIS 11.22 PAUL HARTMANN LIMITED 11.22.1 COMPANY OVERVIEW 11.22.2 SWOT ANALYSIS 11.22.3 REVENUE ANALYSIS 11.22.4 PRODUCT PORTFOLIO 11.22.5 RECENT DEVELOPMENTS 11.22.5 DATA BRIDGE ANALYSIS 12 APPENDIX 12.1. EPIDEMIOLOGY DATA 12.2. SOURCES AND BIBLIOGRAPHY 12.3. RELATED REPORTS 12.4. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK 13 ABOUT DATA BRIDGE MARKET RESEARCH